Performance for Resection for Primary Lung Cancer Compared to STS and National Outcomes*
* These NIS data are the most recent data available at this time. There are more resection for primary lung cancer patients in a single year of NIS data than in the GTSD, so a decision was made to use 3 years of STS GTSD data.
Resection for Primary Lung Cancer Composite Measure Rating (July 2022 - June 2025)
| Overall Composite Score |
99.0%
(98.7 - 99.3)
|
99% (98.7, 99.3)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
| Absence of Operative Mortality |
99.4%
(99.0 - 99.6)
|
99.4% (99, 99.6)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
| Absence of Major Morbidity |
95.5%
(94.1 - 96.8)
|
95.5% (94.1, 96.8)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
Esophagectomy Composite Measure Rating (July 2022 - June 2025)
| Overall Composite Score |
95.5%
(93.3 - 97.4)
|
95.5% (93.3, 97.4)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
| Absence of Operative Mortality |
97.2%
(94.5 - 98.9)
|
97.2% (94.5, 98.9)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
| Absence of Major Morbidity |
82.0%
(73.1 - 89.4)
|
82% (73.1, 89.4)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
Resection for Primary Lung Cancer Overall Composite Score represents two domain scores in a single number:
- Absence of Operative Mortality: Proportion of primary lung cancer resection (i.e., wedge resection, segmentectomy, lobectomy, sleeve lobectomy, bilobectomy, pneumonectomy) patients [risk-adjusted] who do not experience operative mortality. Operative mortality is defined as hospital death, death within 30 days of surgery, or discharge to hospice.
- Absence of Major Morbidity: Proportion of primary lung cancer resection (i.e., wedge resection, segmentectomy, lobectomy, sleeve lobectomy, bilobectomy, pneumonectomy) patients [risk-adjusted] who do not experience any major morbidity. Major morbidity is defined as the presence of any of the following postoperative conditions: tracheostomy, respiratory failure/reintubation, initial ventilatory support>48 hours, ARDS, bronchopleural fistula, pulmonary embolus, pneumonia, unexpected return to OR, myocardial infarct.
Esophagectomy for Esophageal Cancer Composite Score represents two domain scores in a single number:
- Absence of Operative Mortality: Proportion of patients [risk-adjusted] who did not experience operative mortality. Operative mortality is defined as death during the same hospitalization as surgery, death within 30 days of surgery, or discharge to hospice.
- Absence of Major Morbidity: Proportion of patients [risk-adjusted] who did not experience any major complication. These are: 1) unexpected return to the operating room; 2) anastomotic leak requiring medical treatment only (Type 1 and Type 2); 3) respiratory failure/reintubation; 4) initial ventilator support >48 hours; 5) pneumonia; 6) new renal failure per RIFLE criteria; 7) recurrent laryngeal nerve paresis.
